FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Omni Bio Announces U.S. Patent Action for Its Recombinant Alpha-1 Antitrypsin Molecule
November 06, 2013
Omni Bio Pharmaceutical Appoints Dr. Michael Kamarck as New Director
February 06, 2013
Omni Bio Pharmaceutical CEO Provides Company Update
January 31, 2013
Omni Bio Pharmaceutical's Commercial Strategy Is Reinforced by New Data Supporting the Expanded Use of Alpha-1 Antitrypsin in the Treatment of Medical Conditions Such as Type 1 Diabetes
November 14, 2012
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here